| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |